War-torn countries like Darfur, Afghanistan and Iraq are often unable to address even the most basic medical needs of their citizens. A unique volunteer effort, called ‘iCons in Medicine,' could soon change that, using new advances in telemedicine to provide much needed assistance to medical care providers in these areas. Dr. William Kennedy Smith, founding president of iCons in Medicine and the Center for International Rehabilitation in Chicago, tells host Bruce Japsen about an effort to get 300 volunteer physicians to provide 1,000 hours of free consultations to their medical colleagues working in regions ravaged by war, poverty and other devastating conditions.
A Telemedicine Consult in War-Torn Areas
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
War-torn countries like Darfur, Afghanistan and Iraq are often unable to address even the most basic medical needs of their citizens. A unique volunteer effort, called ‘iCons in Medicine,' could soon change that, using new advances in telemedicine to provide much needed assistance to medical care providers in these areas. Dr. William Kennedy Smith, founding president of iCons in Medicine and the Center for International Rehabilitation in Chicago, tells host Bruce Japsen about an effort to get 300 volunteer physicians to provide 1,000 hours of free consultations to their medical colleagues working in regions ravaged by war, poverty and other devastating conditions.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 credits
<p>Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
Clinician's Roundtable
AI and Hair Loss: Measuring Progress with Data-Driven Insights
<p>AI and Hair Loss: Measuring Progress with Data-Driven Insights</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
<p>Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial</p>
ACC Action Center
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
<p>Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?